Tuesday, July 29, 2014 - 14:58
People with chronic hepatitis C who are using methadone or buprenorphine to manage opiate addiction can be safely and effectively treated with AbbVie's 3D all-oral direct-acting antiviral regimen plus ribavirin, resulting in a 97% cure rate, according to a report this week at the 20th International AIDS Conference in Melbourne.
Tuesday, July 29, 2014 - 14:56
The hepatitis C virus (HCV) World Community Advisory Board (CAB) grew from an international AIDS activist movement. The objectives of the meeting were threefold:
To provide a forum for leading activists to learn about developments in HCV treatment and access barriers;
To find common advocacy strategies; and
To meet with pharmaceutical companies about their plans for low- and middle-income countries (LMICs).
Tuesday, July 29, 2014 - 14:48
The importance of integrating people who inject drugs into HCV treatment programs. Arguments from a public health and human rights perspective. This document develops core arguments for why it is relevant, feasible, and indeed crucial to include people who inject drugs in national treatment guidelines and programs for chronic HCV infection – from both public health and human rights perspectives.
Tuesday, July 29, 2014 - 14:40
To better quantify the important role of state health departments in assuring hepatitis C (HCV) testing is available to populations most impacted, NASTAD conducted a survey of health department supported HCV testing activities in 2013.
Tuesday, July 29, 2014 - 14:35
Women In Government has developed a Hepatitis C Awareness and Education Toolkit, which is designed to provide legislators with the background and tools to enact sound policies addressing current and future issues in hepatitis C detection, prevention, and management.
Saturday, May 7, 2011 - 14:03
Saturday, May 7, 2011 - 14:02
NVHR advocacy brief based on the findings of the IOM report on viral hepatitis